Investors Swarm To Healthcare Stocks! BPI, APOL, ESI, ILMN, GILD, ESRX, HLF BTK, XLV
Seeking Alpha Analyst Since 2007
On Tuesday, I wrote an article of education stocks. While the market took a hit on Wednesday, led by heavy selling in commodity stocks, education stocks hardly budged. In fact, they are trading even higher. BPI is now above its earnings high. APOL propelled up +2.22% today, while ESI jumped more than +5% (remember that $80 level?).
Another sector that has pretty much been unaffected by the recent correction in commodities is healthcare. XLV, the SPDR Healthcare ETF, just recorded a new 52-week high today and is on its way to challenge its all-time high of $37.89 set back in October 2007. BTK, the biotech index, is at its all-time high, closing just above 1500 today!
Here are four healthcare stocks that I like and are still on their way up:
ILMN had recently delivered another strong quarter. After a week of sideways trading after earnings, ILMN broke above the resistance at around $73 this week. ILMN could see $80+ before the end of the month.
ESRX has run up quite a bit in the past 2 weeks. However, I think it is heading higher into the $60s. It just broke above the resistance at $59 and still looks really strong.
HLF reported a blowout quarter 2 weeks ago, with a 69% rise in its net income. Its stock popped nearly 15% the day after, and has continued to rise even more since, closing today at $106.69. The company has also announced a 2-for-1 stock split effective as of 5/18. While the stock has risen a lot, the median analyst target on this stock is $115. I think we'll soon see this above $110.
GILD climbed +1.28% today as the latest study showed that early drug treatment reduces HIV transmission by 96%. GILD has recently bounced off of the support at $39. It is climbing towards the resistance at $42.5, above which we could see the $50 level tested.
Good night and HappyTrading! ™
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.